- AdventHealth Research Institute
Dr. Kirk Erickson, PhD, Director of Translational Neuroscience Research at AdventHealth, recently joined the NavNeuro podcast to discuss the powerful connection between physical activity and brain health.
In collaboration with NavNeuro, Dr. Erickson shared research-backed insights into how exercise supports neuroplasticity, memory, and long-term cognitive resilience. His work continues to shape the way we understand healthy aging and brain vitality.
Click below to listen to the full episode.
Recent News
Under the leadership of principal investigator Michael Seidman, MD, AdventHealth Research Institute is participating in the multi-site Clinical Trial of Etanercept (TNF-alpha Blocker) for Treatment of...
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
Results From IGNITE Research Study Published in the Medical Journal "Age and Ageing"
“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism, introduces a metagenomics-powered approach to accurately track dietary intake...
The AdventHealth Cancer Institute has been recognized in Becker's Hospital Review as one of the top 100 hospitals and health systems in the country for its excellence in oncology.
Dr. Wassim McHayleh featured in article about breast cancer research.
In this blog Dr. Amir Kachooei shares his view on AdventHealth's orthopedic research efforts and the future of orthopedic medicine.
Florida Trend for Breast Cancer Month features Dr. McHayleh and his clinical trial Tropion! A participant in the study was declared cancer-free after about 5 months of treatment.
Dr. Daryl Osbahr serves as team orthopedic surgeon and team physician for U.S. Men's National Soccer Team.
and helps the team hit health goals during summer events.
In a recent study, health complications dropped by 24 percent in those taking semaglutide, the active ingredient in Ozempic and Wegovy.
Richard E. Pratley, MD | The Becker's Healthcare Podcast features Dr. Pratley discussing the FLOW study. In this episode, Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute...